title: Specific keynote: chemoprevention of ovarian cancer: the journey begins.
authors.affiliation: Fox Chase Cancer Center.
authors.forename: Robert F
authors.initials: RF
authors.lastname: Ozols
authors.forename: Mary B
authors.initials: MB
authors.lastname: Daly
authors.forename: Andres
authors.initials: A
authors.lastname: Klein-Szanto
authors.forename: Thomas C
authors.initials: TC
authors.lastname: Hamilton
authors.forename: Robert C
authors.initials: RC
authors.lastname: Bast
authors.forename: Molly A
authors.initials: MA
authors.lastname: Brewer
mesh_terms: D016588:Anticarcinogenic Agents / Q000627:therapeutic use*; D003276:Contraceptives, Oral / Q000627:therapeutic use; D005260:Female; D017313:Fenretinide / Q000627:therapeutic use; D006801:Humans; D010051:Ovarian Neoplasms / Q000235:genetics / Q000517:prevention & control*; D010052:Ovariectomy; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors
chemical_list: D016588:Anticarcinogenic Agents; D003276:Contraceptives, Oral; D017313:Fenretinide